Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecular Imaging Predicts Risk for Abdominal Aortic Aneurysms

By HospiMedica International staff writers
Posted on 17 Oct 2013
Several newly identified markers could provide valuable insight to predict the risk of rupture abdominal aortic aneurysms (AAA), according to new research out of Europe.

The study’s findings were published in the October 2013 issue of the Journal of Nuclear Medicine. Positron emission tomography/computed tomography (PET/CT) imaging sans revealed that dense white blood cells in the outermost connective tissue in the vascular wall, increased C-reactive protein and a loss of smooth muscle cells in the middle layer of the vascular wall are all factors that may indicate future AAA rupture. More...


An abdominal aneurysm causes stress on the wall of the aorta, which can rupture it. Rupture of AAA is the 13th leading cause of death in western society and leads to substantial morbidity and mortality in the aging population. AAA is typically asymptomatic; therefore, it is an effective prediction of a rupture is crucial.

To determine potential markers that could be predictive of AAA rupture, researchers conducted 18F-FDG PET/CT scans on 18 patients with AAA diagnosed by ultrasound. Ten of the patients had no uptake of the 18F-FDG, while eight had positive uptake of the imaging agent. Biopsy specimens were then retrieved from each of the patients; patients with positive 18F-FDG uptake had tissue taken from both the site of the positive uptake and a distant negative site of the aortic wall.

“Our approach allows us—for the first time to our knowledge—to analyze spots of high 18F-FDG uptake and compare them to a distant inactive zone of the same aneurysm. We further compared these biopsies to fragments collected in patients with negative 18F-FDG uptake. This strategy allowed for the discrimination of biologic alterations associated with 18F-FDG uptake that would help identify relevant biologic markers predictive of rupture,” said Audrey Courtois, PhD, from the laboratory of connective tissues biology, GIGA-R, University of Liège (Belgium), and lead author of the study.

The tissue from the area of positive 18F-FDG uptake were characterized by an increased number of inflammatory cells in the outermost connective tissue, a high level of C-reactive protein and an extreme decrease in smooth muscle cells, as compared to the biopsies from areas of no uptake. Furthermore, an increase in several matrix metalloproteinase enzymes was seen in the tissue with positive 18F-FDG uptake.

“These data suggest that a PET scan with positive 18F-FDG uptake provide diagnostic support to proceed without delay to aneurysm surgery, despite a person’s age or operative risk. However, the absence of FDG uptake at the level of the aneurismal aortic wall can help us make a safe decision to avoid unnecessary surgery and decrease the burden of healthcare costs,” concluded Dr. Courtois. “This 18F-FDG PET/CT study, with an arterial phase CT, allows us to fully characterize the disease, including the conventional risk factors such as the size of the aneurysm. Although much of the current research is being conducted in the field of oncology, the current study further strengthens 18F-FDG PET/CT as a decisive tool in the management of inflammatory disorders.”

Related Links:

University of Liège



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Rapid Sepsis Test
SeptiCyte RAPID
New
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image

Explainable AI Tool Improves Brain Disorder Screening from 4D fMRI

Functional magnetic resonance imaging (fMRI) captures changes in brain activity over time, but the resulting image sequences can be difficult to analyze. Screening for brain disorders requires assessing... Read more

Critical Care

view channel
Image: Liposomes have long been used for gradual drug delivery, with their composition controlling release speed, potency, duration, and potential toxicity. (Image Credit: iStock)

New Drug Delivery System Extends Release of Local Anesthetic for Weeks

Local anesthetics used for nerve blocks often provide pain relief for only a limited period, while perioperative pain can persist much longer. Extending the duration of a nerve block therefore requires... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.